Screener
Exelixis EXEL Discounts and allowances — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Exelixis in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Exelixis’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q3 2026
- Accession
- 0000939767-26-000098
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Product revenues: | ||||
| Gross product revenues | $812,782 | $745,280 | $1,608,136 | $1,466,991 |
| Discounts and allowances | (239,757) | (225,266) | (480,134) | (433,694) |
| Net product revenues | 573,025 | 520,014 | 1,128,002 | 1,033,297 |
| Collaboration revenues: | ||||
| License revenues | 59,810 | 49,301 | 116,758 | 91,781 |
| Collaboration services revenues | (4,145) | (1,054) | (5,258) | (1,370) |
| Collaboration revenues | 55,665 | 48,247 | 111,500 | 90,411 |
Item 1. Financial Statements.
FAQ
- What is Exelixis's discounts and allowances — total revenues?
- Exelixis (EXEL) reported discounts and allowances — total revenues of -$239.76M in Q2 2026.
- How has Exelixis's discounts and allowances — total revenues changed year-over-year?
- Exelixis's discounts and allowances — total revenues decreased by 6.4% year-over-year, from -$225.27M to -$239.76M.
- What is the long-term trend for Exelixis's discounts and allowances — total revenues?
- Over 4 years (2021 to 2025), Exelixis's discounts and allowances — total revenues has grown at a 24.0% compound annual growth rate (CAGR), from -$375.66M to -$889M.
- What does discounts and allowances — total revenues mean?
- This metric represents the total value of deductions taken against gross product sales, including rebates, chargebacks, cash discounts, and returns. It reflects the difference between the gross invoice price and the net revenue recognized by the company for its pharmaceutical products. Monitoring these adjustments is critical for assessing the actual realized pricing power and the impact of managed care contracting on the company's top-line performance.
Ask your AI about Exelixis's discounts and allowances — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude